New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
09:19 EDTLAYN, ISIS, DARA, WFT, ETRM, AKS, ACMP, WMB, BLUE, LVLT, TWTC, SNDK, FIO, MDT, COVOn The Fly: Pre-market Movers
HIGHER: Covidien (COV), up 30% after Medtronic (MDT) agreed to acquire the company for $42.9B in cash and stock. Medtronic shares are also up 6% following the news... Fusio-io (FIO), up 24% after SanDisk (SNDK) to acquire the company in all-cash deal valued at approximately $1.1B... tw telecom (TWTC), up 11% after agreeing to be acquired by Level 3 (LVLT) for $40.86 per share. Level 3 shares are up 1% following the announcement... Bluebird bio (BLUE), up 63% after announcing data from a clinical study... Williams Companies (WMB), up 12.3% after Access Midstream (ACMP) confirms Williams' planned acquisition... AK Steel (AKS), up 5% after upgraded at BofA Merrill Lynch... Dara BioSciences (DARA), up 21% after KRN5500 granted orphan drug designation by FDA. LOWER: Weatherford (WFT), down 3% after holders approve change of jurisdiction from Switzerland to Ireland... Layne Christensen (LAYN), down 12% after reporting a greater than expected Q1 loss per share and lower than expected revenues.
News For COV;MDT;FIO;SNDK;TWTC;LVLT;BLUE;WMB;ACMP;AKS;ETRM;WFT;DARA;ISIS;LAYN From The Last 14 Days
Check below for free stories on COV;MDT;FIO;SNDK;TWTC;LVLT;BLUE;WMB;ACMP;AKS;ETRM;WFT;DARA;ISIS;LAYN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 22, 2014
12:39 EDTISISThese five companies will benefit from increased ALS awareness, MarketWatch says
A recent surge in funding for Lou Gehrig's disease, or ALS, caused by the Ice Bucket challenge that is widespread on social media outlets, will benefit five pharmaceutical companies that are involved in the development of a cure for ALS, according to MarketWatch. The companies that are or have been involved in developing a treatment for ALS include Biogen Idec (BIIB), Avanir Pharmaceuticals (AVNR), Isis Pharmaceuticals (ISIS), Sanofi (SNY), and Bristol-Myers Squibb (BMY), MarketWatch added. Reference Link
10:42 EDTAKSAnalyst says tariff threat could protect steelmakers
Subscribe for More Information
10:01 EDTAKSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:01 EDTAKSSteel price outlook raised at UBS
Subscribe for More Information
07:01 EDTCOVCovidien acquires Reverse Medical, terms not disclosed
Subscribe for More Information
06:43 EDTAKSAK Steel upgraded to Neutral from Sell at UBS
Subscribe for More Information
06:26 EDTAKSAK Steel upgraded to Neutral from Sell at UBS
Subscribe for More Information
05:44 EDTSNDKStocks with implied volatility below IV index mean; SNDK WAG
Stocks with implied volatility below IV index mean; SanDisk (SNDK) 23, Walgreen (WAG) 20 according to iVolatility.
August 21, 2014
16:16 EDTWMBWilliams confirms 32% Q3 dividend raise, dividend-growth guidance
Subscribe for More Information
08:49 EDTSNDKSanDisk gross margins to get boost from FIO, says Sterne Agee
Sterne Agee expects SanDisk's gross margins to be boosted from the integration of the FIO Enterprise SSD unit, whose acquisition closed on July 23. The firm adds that the company's new Malaysia factory should drive its tax rate lower over time. Sterne Agee keeps a $125 price target and Buy rating on the shares.
06:12 EDTSNDKDRAM prices making downward correction with oversupply concerns, DigiTimes says
Subscribe for More Information
05:50 EDTSNDKStocks with implied volatility movement; QCOM SNDK
Subscribe for More Information
August 20, 2014
08:47 EDTMDTMedtronic valuation attractive, says Morgan Stanley
Morgan Stanley said Medtronic's (MDT) valuation is attractive given pipeline execution, margin growth and shareholder returns, and expectations for the Covidien (COV) deal to go through. Shares are Overweight rated
07:18 EDTMDT, COVMedtronic shares have upside with or without deal, says Deutsche Bank
Deutsche Bank sees limited downside risk and significant upside potential for shares of Medtronic (MDT), with or without the pending Covidien (COV) acquisition. Deutsche says the Q1 results show improving trends and it keeps a Buy rating on Medtronic with an $85 price target.
August 19, 2014
12:17 EDTTWTCtw telecom says 'applauds OMB approval of FCC's special access request'
tw telecom Senior Vice President of Public Policy Michael Rouleau issued the following statement following the Office of Management and Budget's approval of the Federal Communication Commission's special access data collection request. The request will help expedite the FCC's review of incumbent business broadband service providers' market power: "tw telecom applauds the OMB for its approval of the FCC's special access data collection request, helping pave the way for the Commission's review of business broadband service providers' market power, business practices, and pricing. The FCC's access to this pertinent market data will help open the window to increased competition in the industry. tw telecom thanks the OMB and the FCC for their continued efforts toward resolving this long-standing issue, and urges the Commission to issue the data request as soon as possible."
08:40 EDTMDTMedtronic sees FY15 gross margin of 74.5%-75%, with Q2 on lower end of range
Subscribe for More Information
08:25 EDTMDTMedtronic: Negative factors in Spine segment in Q1 werre temporary
Subscribe for More Information
08:22 EDTCOV, MDTMedtronic: We will continue to pay significant US taxes following Covidien deal
Subscribe for More Information
07:19 EDTMDTMedtronic backs FY15 EPS view of $4.00-$4.10, consensus $4.04
Subscribe for More Information
07:17 EDTMDTMedtronic reports Q1 EPS 93c, consensus 92c
Reports Q1 revenue $4.27B, consensus $4.25B.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use